Justin Ezekowitz

发表

Effects of age, gender, and risk‐factors for heart failure on native myocardial T1 and extracellular volume fraction using the SASHA sequence at 1.5T

Richard B Thompson, Kelvin Chow, Jason Dyck, 2018, Journal of magnetic resonance imaging : JMRI.

Leveraging electronic health records for clinical research

Keith Marsolo, Sudha R. Raman, Norman Stockbridge, 2018, American heart journal.

Metabolomic Fingerprint of Heart Failure with Preserved Ejection Fraction

David S. Wishart, Beomsoo Han, Rupasri Mandal, 2015, PloS one.

Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review.

Ben Vandermeer, Donna M Dryden, Brian H Rowe, 2007, JAMA.

Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)

Hiroyuki Tsutsui, Tim Friede, Adrian F Hernandez, 2020, European heart journal.

Predicting the risk of unplanned readmission or death within 30 days of discharge after a heart failure hospitalization.

Carl van Walraven, Padma Kaul, C. van Walraven, 2012, American heart journal.

Meta-analysis: -Blocker Dose, Heart Rate Reduction, and Death in Patients With Heart Failure

Natasha Wiebe, Paul Armstrong, P. Armstrong, 2009, Annals of Internal Medicine.

Subclinical Pulmonary Edema Is Associated With Reduced Exercise Capacity in HFpEF and HFrEF.

Richard B Thompson, Kelvin Chow, Ian Paterson, 2017, Journal of the American College of Cardiology.

Systematic Review: Cardiac Resynchronization in Patients with Symptomatic Heart Failure

Lisa Hartling, Brian Rowe, Carol Spooner, 2004, Annals of Internal Medicine.

Usefulness of spironolactone in a specialized heart failure clinic.

Paul W Armstrong, P. Armstrong, F. McAlister, 2004, The American journal of cardiology.